Relating to the scheduling of certain controlled substances in response to certain actions by the United States Food and Drug Administration.

This Texas bill (SB 2997) requires the state's health commissioner to automatically adjust Texas' controlled substance schedules when the U.S. Food and Drug Administration (FDA) approves a Schedule I drug under federal law (21 U.S.C. § 355) and subsequently removes it from controlled substances or moves it to a lower schedule. It directly affects Texas' drug scheduling authority, mandating that the commissioner delete or reschedule such substances within 21 days of federal action. The key mechanism is a 21-day deadline for Texas to align its schedules with federal changes for FDA-approved Schedule I drugs, bypassing public hearings for these specific cases. The bill applies only to substances affected by federal scheduling changes occurring on or after its effective date (September 1, 2025).